Tag: tenofivir

1. HIV-1 acquisition rates were significantly lower in men who used tenofovir-disoprovil fumarate (TDF) and emtricitabine (FTC) preexposure prophylaxis (PrEP). 2. TDF-FTC was associated with significantly higher rates of gastrointestinal (GI) complaints and elevated serum creatinine levels. Evidence Rating Level: 1 (Excellent) Study Rundown: Studies have shown potential for effective PrEP of...
1. In this randomized open-label trial, pre-exposure prophylaxis (PrEP) with once daily tenofovir-emtricitabine was found effective in preventing HIV-1 infection in high-risk gay men. 2. In the group using PrEP, an increased rate of sexual partners or sexually transmitted disease was not observed. Evidence Rating Level: 1 (Excellent) Study Rundown: Although...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women Pre-exposure prophylaxis with tenofovir combined with or without emtricitabine has been shown to significantly reduce rates of HIV acquisition in populations including men...